Search Results for 'abbott'
-
Diagnostics
Abbott Launches COVID-19 Antibody Blood Test
Abbott begins shipping April 16 and intends to distribute 4 million tests in April.PR Newswire 04.15.20
-
Bigfoot Biomedical Raises $45M, Led by Abbott
Funds to support breakthrough therapy for 6M living with insulin-requiring type 1 and type 2 diabetes.Bigfoot Biomedical 01.13.20
-
Cardiovascular | Diagnostics
Abbott’s Heart Attack Blood Test Cleared
Newly cleared diagnostic test could help identify heart attacks several hours sooner than standard troponin tests.PR Newswire 09.27.19
-
Cardiovascular | Surgical
Abbott to Acquire Cephea Valve Technologies
Acquisition to further bolster Abbott's position in therapies for mitral valve disease, the most common type of heart valve ailment.Abbott Laboratories 01.16.19
-
Cardiovascular | Surgical
FDA Approves Abbott's Device to Close Holes in Premature Infants' Hearts
First and only minimally invasive, transcatheter treatment approved for premature babies with a patent ductus, a life-threatening opening in their heart.Abbott Laboratories 01.14.19
-
Cardiovascular | Electronics | Software & IT
Abbott Releases New Cyber Updates for Implanted Cardiac Devices
Planned updates designed to provide new patient management tools and further protection against unauthorized access.Abbott Laboratories 08.29.17
-
10. Abbott Laboratories
$10.1 Billion ($20.9B total) KEY EXECUTIVES: Miles D. White, Chairman and CEO Brian J. Blaser, Exec. VP, Diagnostics Products Robert B. Ford, Exec. VP, Medical Devices Michael T. Rousseau, President, Cardiovascular and Neuromodulation Br…07.26.17
-
Software & IT | Testing
The Curious Case of Abbott and Alere
As MPO readers are certainly aware, Abbott Laboratories has been quite active in the M&A department this year. Following the string of medtech industry consolidation efforts—which shows absolutely no signs of slowing—Abbott purchased…Sam Brusco, Associate Editor 10.12.16
